Nicht aus der Schweiz? Besuchen Sie lehmanns.de

Fibrinolytic Bacterial Enzymes with Thrombolytic Activity

(Autor)

Buch | Softcover
XII, 74 Seiten
2012 | 2012
Springer Berlin (Verlag)
978-3-642-24979-2 (ISBN)
CHF 74,80 inkl. MwSt

Stress, high blood pressure, smoking, pollution, fast foods, overweight, excessive travelling, surgery, less movement are common features in our modern life. These features are risky for blood clotting disorders. According to WHO, over 29% of the total mortalities worldwide are due to thrombosis. By the year, 2020 cardiovascular diseases (CVDs) may cause an estimated 25 million deaths per year, thus antithrombotic therapy is of great interest.

The available thrombolytic agents such as urokinase are highly expensive, antigenic, quite unspecific, pyretogenic and hemorrhagenic. Therefore, the production of fibrinolysing enzymes, which rapidly dissolute thrombi within the vascular tree, without the detriments by microorganisms, as described in this book, is the desirable aim of today's research.

Erscheint lt. Verlag 5.1.2012
Reihe/Serie SpringerBriefs in Microbiology
Zusatzinfo XII, 74 p. 15 illus., 6 illus. in color.
Verlagsort Berlin
Sprache englisch
Maße 155 x 235 mm
Gewicht 148 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Mikrobiologie / Infektologie / Reisemedizin
Medizin / Pharmazie Studium
Naturwissenschaften Biologie Mikrobiologie / Immunologie
Schlagworte Blood clots • Streptokinase • thrombosis
ISBN-10 3-642-24979-5 / 3642249795
ISBN-13 978-3-642-24979-2 / 9783642249792
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
und Erste Hilfe an Bord

von Jürgen Graf; Jochen Hinkelbein

Buch | Softcover (2024)
MWV Medizinisch Wissenschaftliche Verlagsgesellschaft
CHF 55,90